EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Delivery of Doxorubicin by Ferric Ion-Modified Mesoporous Polydopamine Nanoparticles and Anticancer Activity against HCT-116 Cells In Vitro

Mengwen Guo, Junhong Ling iD, Xinyi Xu, Xiaokun Ouyang iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24076854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Mengwen Guo und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China. Hauptthemen laut MEDLINE: Ferric Compounds, Nanoparticles. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic Public Welfare Research Project of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In clinical cancer research, photothermal therapy is one of the most effective ways to increase sensitivity to chemotherapy. Here, we present a simple and effective method for developing a nanotherapeutic agent for chemotherapy combined with photothermal therapy. The nanotherapeutic agent mesoporous polydopamine-Fe(III)-doxorubicin-hyaluronic acid (MPDA-Fe(III)-DOX-HA) was composed of mesoporous polydopamine modified by ferric ions and loaded with the anticancer drug doxorubicin (DOX), as well as an outer layer coating of hyaluronic acid. The pore size of the mesoporous polydopamine was larger than that of the common polydopamine nanoparticles, and the particle size of MPDA-Fe(III)-DOX-HA nanoparticles was 179 ± 19 nm. With the presence of ferric ions, the heat generation effect of the MPDA-Fe(III)-DOX-HA nanoparticles in the near-infrared light at 808 nm was enhanced. In addition, the experimental findings revealed that the active targeting of hyaluronic acid to tumor cells mitigated the toxicity of DOX on normal cells. Furthermore, under 808 nm illumination, the MPDA-Fe(III)-DOX-HA nanoparticles demonstrated potent cytotoxicity to HCT-116 cells, indicating a good anti-tumor effect in vitro. Therefore, the system developed in this work merits further investigation as a potential nanotherapeutic platform for photothermal treatment of cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ferric CompoundsNanoparticlesHumansHCT116 CellsHyaluronic AcidDrug Delivery SystemsDoxorubicinIronIonsIndolesPolymersDiazonium CompoundsPyridines

Stichwörter der Autor:innen

doxorubicin (DOX)ferric ionshyaluronic acid target modificationmesoporous polydopamine

Substanzen

Ferric CompoundsHyaluronic AcidDoxorubicinIronIonspolydopamineIndolesPolymers3-(2'-pyridyldithio)benzyldiazoacetateDiazonium Compounds

Autor:innen und Institutionen

  • School of Food and Pharmacy, Zhejiang Ocean University, Zhoushan 316022, China.

ORCID-Profile: Junhong Ling, Xiaokun Ouyang

Förderung

  • Basic Public Welfare Research Project of Zhejiang Province

Zitieren

APA

Guo, M., Ling, J., Xu, X., & Ouyang, X. (2023). Delivery of Doxorubicin by Ferric Ion-Modified Mesoporous Polydopamine Nanoparticles and Anticancer Activity against HCT-116 Cells In Vitro. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24076854

Vancouver

Guo M, Ling J, Xu X, Ouyang X. Delivery of Doxorubicin by Ferric Ion-Modified Mesoporous Polydopamine Nanoparticles and Anticancer Activity against HCT-116 Cells In Vitro. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24076854

BibTeX
@article{Guo2023,
  author = {Guo, Mengwen and Ling, Junhong and Xu, Xinyi and Ouyang, Xiaokun},
  title = {Delivery of Doxorubicin by Ferric Ion-Modified Mesoporous Polydopamine Nanoparticles and Anticancer Activity against HCT-116 Cells In Vitro},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24076854}
}
Kostenlos starten →